Feiba purpose of the drug:
– treatment and prevention of bleeding in patients with inhibitory form of hemophilia A;
– treatment and prevention of bleeding in patients with inhibitory form of hemophilia B;
– treatment and prevention of bleeding in patients with acquired coagulopathies due to inhibitors to factors VIII, IX and XI;
– for long-term therapy for IIT (immune tolerance induction program) in combination with factor VIII concentrate to avoid the development of bleeding.
Active ingredient: anti-inhibitor coagulant complex
Prescription medicine.